Optimizing the Treatment Pattern for De Novo Metastatic Nasopharyngeal Carcinoma Patients: A Large-Scale Retrospective Cohort Study
Open Access
- 23 October 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 10, 543646
Abstract
Objectives: To investigate the optimal treatment pattern in patients with de novo metastatic nasopharyngeal carcinoma (NPC). Methods: We assessed 502 consecutive and unselected de novo metastatic NPC patients in Sun Yat-sen University Cancer Center (SYSUCC) from November 2006 to October 2016 in our study. All patients were treated with palliative chemotherapy (PCT) and 308 patients received locoregional radiotherapy (LRRT) subsequently. Our primary study endpoint was overall survival (OS). Results: The patients treated with LRRT were associated with improved survival on univariate analysis (3-year OS rate 63.7% vs. 31.8%, P < 0.001) and multivariate analysis (HR 0.52, 95%CI 0.40–0.68, P < 0.001). The overall survival benefit of more than 4 PCT cycles was significant in female (HR 0.45, 95% CI 0.24–0.86, P = 0.016) and patients with multiple metastatic sites (HR 0.42, 95% CI 0.26–0.66, P < 0.001). The application of concurrent chemotherapy (CCT) was not associated with better survival among patients receiving LRRT (HR 1.31, 95% CI 0.92–1.86, P = 0.141). Conclusion: LRRT prolonged survival in de novo metastatic NPC. For patients treated with multiple metastatic sites, more than 4 cycles of PCT is necessary. CCT does not improve survival in de novo metastatic NPC patients.Keywords
This publication has 31 references indexed in Scilit:
- Triplet combination with paclitaxel, cisplatin and 5-FU is effective in metastatic and/or recurrent nasopharyngeal carcinomaCancer Chemotherapy and Pharmacology, 2012
- Combined High-dose Radiation Therapy and Systemic Chemotherapy Improves Survival in Patients With Newly Diagnosed Metastatic Nasopharyngeal CancerAmerican Journal of Clinical Oncology, 2012
- Immortal Time Bias: A Frequently Unrecognized Threat to Validity in the Evaluation of Postoperative RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Current Management of Nasopharyngeal CancerSeminars in Radiation Oncology, 2012
- Definitive treatment of metastatic nasopharyngeal carcinoma: Report of 5 cases with review of literatureHead & Neck, 2010
- Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225Journal of Clinical Oncology, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Treatment Outcomes of Patients with AJCC Stage IVC Nasopharyngeal Carcinoma: Benefits of Primary RadiotherapyJapanese Journal of Clinical Oncology, 2006
- Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Nasopharyngeal carcinoma: the significance of neck node involvement in relation to the pattern of distant failureBritish Journal of Radiology, 1990